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BACKGROUND
• Chemotherapy-immunotherapies are high risk medications that can include
multi-drug and multi-day regimens with narrow therapeutic indexes and high
risk for toxicities.
• Susceptibility for errors exists if adherence to protocol is inconsistent or if
pertinent patient specific information is omitted (LeFebvre & Smith, 2019).
• Prior to the creation of the “SmartPhrase” in the Electronic Health Record
(EHR) pre-administration safety checks were on paper, not included in the
EHR, not standardized among clinicians, and not completed every time.
• Chart audits revealed a need for consistent, centralized documentation to
enhance patient safety while minimizing professional liability.
• A transdisciplinary team created a “SmartPhrase” template for streamlining
relevant patient specific information and individualizing plans of care.
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CHEMOTHERAPY / IMMUNOTHERAPY ADMINISTRATION NOTE
Day: V for Verification note or Day # of Total Days
Cancer Diagnosis: Free Text
Hospital Admission Diagnosis: Free Text
CHEMOTHERAPY/IMMUNOTHERAPY
Protocol Deviation: No / Yes with Explanation
Treatment Plan & Dosages Verified by RN and Pharmacist: Yes / No
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Dosage
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Action

Dose # of total
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IV
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IT

Given
Infusing
Initial Verification/RN Check
Rate Adjusted See MAR
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Comments (dose
adjustment,
reactions, rate
change reason,
held)
Free Text

*Lines can be added for multiple drug regimens

PURPOSE

Nursing Comments: Free Text
PRE-ADMINISTRATION CHECK

• Create a documentation template which includes the nine components
recommended by ONS guidelines for completed chemotherapyimmunotherapy pre-administration checks (Neuss, et al., 2017).
• Improve patient-centered care and transitions in care.

GOALS
• Standardization of chemotherapy-immunotherapy pre-administration
documentation to promote safety.
• Foster safe and seamless patient centered care throughout inpatient and
outpatient settings and service lines.
• Ensure ONS recommendations for pre-administration checks includes a
documented dual verification process.
• 95% or greater compliance in use of the “SmartPhrase”.

RESULTS AND OUTCOMES
• Practitioner utilization of the “SmartPhrase” exceeded the project goal of
95% after implementation.
• Change from baseline use of “SmartPhase” documentation in the specific key
areas: dual verification (↑100%), diagnosis and protocol (↑69%), drugs
(maintained 100% utilization), consent (↑54%), education (↑37%), blood
return (↑29%), dosages (↓6%), initial labs (↓6%), schedule (↑3%).
• Improved documentation and facilitated communication between providers
within inpatient and outpatient settings and service lines.
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Consent Signed: Yes / No
Body surface area is *AUTO POPULATES* meters squared.

CONCLUSIONS/DISCUSSION

Review of Labs: Yes / No
Urine PH within administration parameters (if applicable): Yes / No / NA
Lab Results
Component
*AUTO POPULATES*

Value

Date

Education: Patient received drug information from Micromedex and verbalizes understanding of side effects and
toxicities: Yes / No
Patient was advised to report symptoms or pain/discomfort at infusion site: Yes / No
Plan of Care Initiated/Updated: Yes / No
Condition of IV Site Pre-Treatment:
Line Type
Blood
Return
Pt has a port, tunneled line, PICC, Yes / No
non-tunneled line / short term
catheter, peripheral line,
peripheral inserted midline, other

Assessment/Condition
dressing dry and intact
no erythema
no pain or tenderness
Free Text

Comments (Awaiting Tip
Confirmation, tPA, etc.)
Free Text

*Definition of actions available upon request
IM—intramuscular; IT—intrathecal; MAR—medication administration record; NA—not applicable; PICC—peripherally inserted central catheter;
Pt—patient; SQ—subcutaneous; tPA—tissue plasma activator
Note. Image courtesy of Providence Regional Medical Center Everett. Used with permission PRMCE

• Formulated a transdisciplinary team of multiple stakeholders, including
clinical informatics and bedside providers to develop a “SmartPhrase” to
promote rapid access to critical information.
• Developed pre-administration safety checks which included “hard stops” in
the EHR “SmartPhrase” template.
• Formalized education: emails, posters, huddle presentations, and face-toface classes with return demonstration and validation of comprehension and
usage.
• Conducted baseline, three-month, and six-month audits to evaluate for
“SmartPhrase” usage and completion of documentation.
• Solicitated feedback and reported through the transdisciplinary team to
identify opportunities for improvement and barriers to use, leading to
template revisions.
• Re-educated users based on template modifications.
• Incorporated accurate completion of the “SmartPhrase” template via skills
validation during new hire orientation.

• Nurses need to be actively involved in identifying barriers to care delivery to
improve patient safety by initiating quality improvement projects.
• A defined location for the “SmartPhrase” made for easy access between
shifts and future encounters to enhance patient centered care based on
clinical status at time of treatment as well as ongoing treatment tolerance.
• The “SmartPhrase” allowed consistent documentation and dual-verification
of pre-administration safeguards.
• Chart audits helped identify barriers to documentation and delays in care,
providing the opportunity for continued improvement.
• Implementing tools within the EHR based on standards of care and guidelines
decreases organizational liability concerns while promoting safety.

FURTHER RESEARCH/IMPLICATIONS FOR PRACTICE
• Regardless of routes or combination of treatments, the “SmartPhrase” offers
a universal means of documentation in healthcare settings that utilize Epic®
systems (Bakshi & Trivedi, 2018).
• Many organizations and healthcare systems utilize Epic® EHR systems which
offer “SmartPhrases” that can be shared within an individual facility and/or
network of healthcare delivery systems (LeFebvre & Smith, 2019).
• Ensures pre-administration safety checks are completed.
• Completing the “SmartPhase” in advance supports stewardship of resources
including nursing expertise/time, delays in treatment (bed/chair availability,
admission/appointment time), and medication/supply cost.
• Promotes continuity of patient centered care by having a centralized location
in the EHR for ease of retrieval across oncology patient’s ongoing and follow
up treatment.

